Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Shohei Myoba"'
Autor:
Hiroki Ito, Ryosuke Jikuya, Shohei Myoba, Tomoyuki Tatenuma, Go Noguchi, Daiki Ueno, Yusuke Ito, Mitsuru Komeya, Kentaro Muraoka, Masahiro Yao, Hisashi Hasumi, Noboru Nakaigawa, Kazuhide Makiyama
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Renal and ovarian clear cell carcinoma (CCC) are both characterized by a clear cytoplasm and exhibit similar genomic alterations and clinical characteristics. We hypothesized that both CCCs may share clinical biomarker. Tissue factor pathway
Externí odkaz:
https://doaj.org/article/e100b0bb1efe49bb9f24b2411e3ae6d0
Autor:
Mari Uomoto, Yukihide Ota, Yukio Suzuki, Asuna Yumori, Hiroto Narimatsu, Shiro Koizume, Shinya Sato, Yoshiyasu Nakamura, Shohei Myoba, Norihisa Ohtake, Haruya Saji, Etsuko Miyagi, Yohei Miyagi
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Endometrial cancer is the most common gynecological malignancy; however, there is no useful blood diagnostic biomarker. This study aimed to determine the utility of tissue factor pathway inhibitor 2 (TFPI2), a biomarker of ovarian
Externí odkaz:
https://doaj.org/article/0b972ce8dada4faabcf3ff7c7faa693b
Autor:
Motosuke Tsutsumi, Hideki Muto, Shohei Myoba, Mai Kimoto, Akira Kitamura, Masakatsu Kamiya, Takashi Kikukawa, Shigeharu Takiya, Makoto Demura, Keiichi Kawano, Masataka Kinjo, Tomoyasu Aizawa
Publikováno v:
FEBS Open Bio, Vol 6, Iss 2, Pp 106-125 (2016)
Fibroin modulator‐binding protein 1 (FMBP‐1) is a silkworm transcription factor that has a unique DNA‐binding domain called the one score and three amino acid peptide repeat (STPR). Here we used fluorescence correlation spectroscopy (FCS) to an
Externí odkaz:
https://doaj.org/article/1ffeff885ea04c0ca1ee7d7e92d4e6e7
Autor:
Shoichiro Yamanaka, Ryuta Miyake, Yuki Yamada, Ryuji Kawaguchi, Norihisa Ootake, Shohei Myoba, Hiroshi Kobayashi
Publikováno v:
Gynecologic and Obstetric Investigation. 87:133-140
Objectives: Patients with asymptomatic venous thromboembolism (VTE) are associated with an increased risk of pulmonary thromboembolism events. However, due to low specificity and high false-positive rates, D-dimer testing cannot be used alone to diag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f8c73d1f438cd9b42fbc5c52a37faf
https://doi.org/10.1159/000524804
https://doi.org/10.1159/000524804
Autor:
Hiroshi Kobayashi, Yuki Yamada, Ryuji Kawaguchi, Norihisa Ootake, Shohei Myoba, Fuminori Kimura
Publikováno v:
The journal of obstetrics and gynaecology researchReferences. 48(9)
Carbohydrate antigen 125 (CA125), CA19-9, carcinoembryonic antigen (CEA), human epididymis protein 4 (HE4), and the Risk of Ovarian Malignancy Algorithm (ROMA) are widely used as tumor markers and algorithms for the diagnosis of ovarian cancer (OC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd232a0d2d12cb25ada3533972b73f28
https://pubmed.ncbi.nlm.nih.gov/35778814
https://pubmed.ncbi.nlm.nih.gov/35778814
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ryuta, Miyake, Yuki, Yamada, Shoichiro, Yamanaka, Ryuji, Kawaguchi, Norihisa, Ootake, Shohei, Myoba, Hiroshi, Kobayashi
Publikováno v:
Mol Clin Oncol
Tissue factor pathway inhibitor 2 (TFPI2) is a serodiagnostic marker for epithelial ovarian cancer (EOC) and is the primary inhibitor of the extrinsic coagulation pathway. The present study assessed the diagnostic performance of TFPI2 for detecting v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6f59cec162c3a3bdd7f116f718dda94
https://doi.org/10.3892/mco.2021.2479
https://doi.org/10.3892/mco.2021.2479
Autor:
Hisamori Kato, Mitsuyo Yoshihara, Tomoyuki Yokose, Yohei Miyagi, Shinya Sato, Etsuko Miyagi, Shohei Myoba, Yoshiyasu Nakamura, Yukihide Ota, Norihisa Ohtake, Shiro Koizume, Tomoko Takahashi
Publikováno v:
Oncology Reports
Tissue factor pathway inhibitor‑2 (TFPI‑2) is a promising candidate as a serum biomarker of ovarian clear cell carcinoma (OCCC), a lethal histological subtype of epithelial ovarian cancer (EOC). TFPI‑2 is a secreted serine protease inhibitor th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f6d5f459adf2fe2b8c9257dc13789fa
https://pubmed.ncbi.nlm.nih.gov/33650653
https://pubmed.ncbi.nlm.nih.gov/33650653
Autor:
RYUTA MIYAKE, YUKI YAMADA, SHOICHIRO YAMANAKA, RYUJI KAWAGUCHI, NORIHISA OOTAKE, SHOHEI MYOBA, HIROSHI KOBAYASHI
Publikováno v:
Molecular & Clinical Oncology; Feb2022, Vol. 16 Issue 2, p1-5, 5p
Autor:
Shohei Myoba, Masakatsu Kamiya, Tomoyasu Aizawa, Makoto Demura, Motosuke Tsutsumi, Akira Kitamura, Mai Kimoto, Shigeharu Takiya, Keiichi Kawano, Takashi Kikukawa, Masataka Kinjo, Hideki Muto
Publikováno v:
FEBS Open Bio
Fibroin modulator‐binding protein 1 (FMBP‐1) is a silkworm transcription factor that has a unique DNA‐binding domain called the one score and three amino acid peptide repeat (STPR). Here we used fluorescence correlation spectroscopy (FCS) to an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9ba64dcc08587cc6c1388693d36cae6
http://hdl.handle.net/2115/61643
http://hdl.handle.net/2115/61643